Carb_anhydraseEukaryotic-type carbonic anhydrase |
![]() |
|---|
| SMART accession number: | SM01057 |
|---|---|
| Description: | Carbonic anhydrases are zinc metalloenzymes which catalyse the reversible hydration of carbon dioxide to bicarbonate (PUBMED:18336305), (PUBMED:10978542). CAs have essential roles in facilitating the transport of carbon dioxide and protons in the intracellular space, across biological membranes and in the layers of the extracellular space; they are also involved in many other processes, from respiration and photosynthesis in eukaryotes to cyanate degradation in prokaryotes. There are five known evolutionarily distinct CA families (alpha, beta, gamma, delta and epsilon) that have no significant sequence identity and have structurally distinct overall folds. Some CAs are membrane-bound, while others act in the cytosol; there are several related proteins that lack enzymatic activity. The active site of alpha-CAs is well described, consisting of a zinc ion coordinated through 3 histidine residues and a water molecule/hydroxide ion that acts as a potent nucleophile. The enzyme employs a two-step mechanism: in the first step, there is a nucleophilic attack of a zinc-bound hydroxide ion on carbon dioxide; in the second step, the active site is regenerated by the ionisation of the zinc-bound water molecule and the removal of a proton from the active site (PUBMED:9336012). Beta- and gamma-CAs also employ a zinc hydroxide mechanism, although at least some beta-class enzymes do not have water directly coordinated to the metal ion. |
| Interpro abstract (IPR001148): | Carbonic anhydrases (CA: EC 4.2.1.1) are zinc metalloenzymes which catalyse the reversible hydration of carbon dioxide to bicarbonate [(PUBMED:18336305), (PUBMED:10978542)]. The alpha-CAs are found predominantly in animals but also in bacteria and green algae. There are at least 15 isoforms found in mammals, which can be subdivided into cytosolic CAs (CA-I, CA-II, CA-III, CA-VII and CA XIII), mitochondrial CAs (CA-VA and CA-VB), secreted CAs (CA-VI), membrane-associated (CA-IV, CA-IX, CA-XII and CA-XIV) and those without CA activity, the CA-related proteins (CA-RP VIII, X and XI). This entry represents a domain characteristic of alpha class carbonic anhydrases. The dominating secondary structure is a 10-stranded, twisted beta-sheet, which divides the molecules into two halves [(PUBMED:9336012)]. Alpha-CAs contain a single zinc atom bound to three conserved histidine residues. The catalytically active group is the zinc-bound water which ionizes to a hydroxide group. In the mechanism of catalysis, nucleophilic attack of CO2 by a zinc-bound hydroxide ion is followed by displacement of the resulting zinc-bound bicarbonate ion by water; subsequent deprotonation regenerates the nucleophilic zinc-bound hydroxide ion [(PUBMED:8673298), (PUBMED:11493685)]. |
| Family alignment: |
There are 1578 Carb_anhydrase domains in 1570 proteins in SMART's nrdb database.
Click on the following links for more information.
- Evolution (species in which this domain is found)
-
Click on
to expand nodes. To display all proteins with a Carb_anhydrase domain in a specific node, click on it.This tree shows only several representative species. The complete taxonomic breakdown of all proteins with Carb_anhydrase domain is also avaliable.
Useful shortcuts: Expand all nodes or Collapse tree
Go to specific node: Anopheles gambiae, Arabidopsis thaliana, Caenorhabditis elegans, Drosophila melanogaster, Homo sapiens, Mus musculus, Rattus norvegicus, Takifugu rubripes - Cellular role (predicted cellular role)
-
Cellular role: metabolism
- Literature (relevant references for this domain)
-
Primary literature is listed below; Automatically-derived, secondary literature is also avaliable.
- Supuran CT
- Carbonic anhydrases--an overview.
- Curr Pharm Des. 2008; 14: 603-14
- Display abstract
Carbonic anhydrases (CAs, EC 4.2.1.1) are widespread metalloenzymes allover the phylogenetic tree, with at least 4 distinct gene familiesencoding for them. At least 16 different alpha-CA isoforms were isolatedin mammals, where these enzymes play crucial physiological roles.Representatives of the beta-delta-CA family are highly abundant in plants,diatoms, eubacteria and archaea. These enzymes are efficient catalysts forthe reversible hydration of carbon dioxide to bicarbonate, but at leastthe alpha-CAs possess a high versatility, being able to catalyze differentother hydrolytic processes The catalytic mechanism of the alpha-CAs isunderstood in detail: the active site consists of a Zn(II) ionco-ordinated by three histidine residues and a water molecule/hydroxideion. The latter is the active species, acting as a potent nucleophile. Forbeta- and gamma-CAs, the zinc hydroxide mechanism is valid too, althoughat least some beta-class enzymes do not have water directly coordinated tothe metal ion. CAs are inhibited by two classes of compounds: the metalcomplexing anions and the sulfonamides and their isosteres (sulfamates,sulfamides etc.) possessing the general formula RXSO(2)NH(2) (R = aryl;hetaryl; perhaloalkyl; X = nothing, O or NH). At least 25 clinically useddrugs/agents in clinical development show applications as diuretics andantiglaucoma drugs, anticonvulsants, with some compounds being developedas anticancer agents/diagnostic tools for tumors, antiobesity agents, andantimicrobials/antifungals (inhibitors targeting CAs from pathogenicorganisms such as Helicobacter pylori, Mycobacterium tuberculosis,Plasmodium falciparum, Candida albicans, etc). Several importantphysiological and physio-pathological functions are played by CA isozymespresent in organisms all over the phylogenetic tree, related torespiration and transport of CO(2)/bicarbonate between metabolizingtissues and the lungs, pH and CO(2) homeostasis, electrolyte secretion ina variety of tissues/organs, biosynthetic reactions, such as thegluconeogenesis and ureagenesis among others (in animals), CO(2) fixation(in plants and algae), etc. The presence of these ubiquitous enzymes in somany tissues and in so different isoforms, represents an attractive goalfor the design of inhibitors or activators with biomedical applications.
- Smith KS, Ferry JG
- Prokaryotic carbonic anhydrases.
- FEMS Microbiol Rev. 2000; 24: 335-66
- Display abstract
Carbonic anhydrases catalyze the reversible hydration of CO(2)[CO(2)+H(2)Oright harpoon over left harpoon HCO(3)(-)+H(+)]. Since thediscovery of this zinc (Zn) metalloenzyme in erythrocytes over 65 yearsago, carbonic anhydrase has not only been found in virtually all mammaliantissues but is also abundant in plants and green unicellular algae. Theenzyme is important to many eukaryotic physiological processes such asrespiration, CO(2) transport and photosynthesis. Although ubiquitous inhighly evolved organisms from the Eukarya domain, the enzyme has receivedscant attention in prokaryotes from the Bacteria and Archaea domains andhas been purified from only five species since it was first identified inNeisseria sicca in 1963. Recent work has shown that carbonic anhydrase iswidespread in metabolically diverse species from both the Archaea andBacteria domains indicating that the enzyme has a more extensive andfundamental role in prokaryotic biology than previously recognized. Aremarkable feature of carbonic anhydrase is the existence of threedistinct classes (designated alpha, beta and gamma) that have nosignificant sequence identity and were invented independently. Thus, thecarbonic anhydrase classes are excellent examples of convergent evolutionof catalytic function. Genes encoding enzymes from all three classes havebeen identified in the prokaryotes with the beta and gamma classespredominating. All of the mammalian isozymes (including the 10 humanisozymes) belong to the alpha class; however, only nine alpha classcarbonic anhydrase genes have thus far been found in the Bacteria domainand none in the Archaea domain. The beta class is comprised of enzymesfrom the chloroplasts of both monocotyledonous and dicotyledonous plantsas well as enzymes from phylogenetically diverse species from the Archaeaand Bacteria domains. The only gamma class carbonic anhydrase that hasthus far been isolated and characterized is from the methanoarchaeonMethanosarcina thermophila. Interestingly, many prokaryotes containcarbonic anhydrase genes from more than one class; some even contain genesfrom all three known classes. In addition, some prokaryotes containmultiple genes encoding carbonic anhydrases from the same class. Thepresence of multiple carbonic anhydrase genes within a species underscoresthe importance of this enzyme in prokaryotic physiology; however, therole(s) of this enzyme is still largely unknown. Even though most of theinformation known about the function(s) of carbonic anhydrase primarilyrelates to its role in cyanobacterial CO(2) fixation, the prokaryoticenzyme has also been shown to function in cyanate degradation and thesurvival of intracellular pathogens within their host. Investigations intoprokaryotic carbonic anhydrase have already led to the identification of anew class (gamma) and future research will undoubtedly reveal novelfunctions for carbonic anhydrase in prokaryotes.
- Lindskog S
- Structure and mechanism of carbonic anhydrase.
- Pharmacol Ther. 1997; 74: 1-20
- Display abstract
Carbonic anhydrase (CA; carbonate hydro-lyase, EC 4.2.1.1) is azinc-containing enzyme that catalyzes the reversible hydration of carbondioxide: CO2+ H2O<-->HCO3(-)+H+. The enzyme is the target for drugs, suchas acetazolamide, methazolamide, and dichlorphenamide, for the treatmentof glaucoma. There are three evolutionarily unrelated CA families,designated alpha, beta, and gamma. All known CAs from the animal kingdomare of the alpha type. There are seven mammalian CA isozymes withdifferent tissue distributions and intracellular locations, CA I-VII.Crystal structures of human CA I and II, bovine CA III, and murine CA Vhave been determined. All of them have the same tertiary fold, with acentral 10-stranded beta-sheet as the dominating secondary structureelement. The zinc ion is located in a cone-shaped cavity and coordinatedto three histidyl residues and a solvent molecule. Inhibitors bind at ornear the metal center guided by a hydrogen-bonded system comprisingGlu-106 and Thr-199. The catalytic mechanism of CA II has been studied inparticular detail. It involves an attack of zinc-bound OH- on a CO2molecule loosely bound in a hydrophobic pocket. The resultingzinc-coordinated HCO3- ion is displaced from the metal ion by H2O. Therate-limiting step is an intramolecular proton transfer from thezinc-bound water molecule to His-64, which serves as a proton shuttlebetween the metal center and buffer molecules in the reaction medium.
- Structure (3D structures containing this domain)
3D Structures of Carb_anhydrase domains in PDB
PDB code Main view Title 12ca 
Altering the mouth of a hydrophobic pocket. structure and kinetics of human carbonic anhydrase ii mutants at residue val-121 1a42 
Human carbonic anhydrase ii complexed with brinzolamide 1am6 
Carbonic anhydrase ii inhibitor: acetohydroxamate 1avn 
Human carbonic anhydrase ii complexed with the histamine activator 1azm 
Drug-protein interactions: structure of sulfonamide drug complexed with human carbonic anhydrase i 1bcd 
X-ray crystallographic structure of a complex between human carbonic anhydrase ii and a new topical inhibitor, trifluoromethane sulphonamide 1bic 
Crystallographic analysis of thr-200-> his human carbonic anhydrase ii and its complex with the substrate, hco3- 1bn1 
Carbonic anhydrase ii inhibitor 1bn3 
Carbonic anhydrase ii inhibitor 1bn4 
Carbonic anhydrase ii inhibitor 1bnm 
Carbonic anhydrase ii inhibitor 1bnn 
Carbonic anhydrase ii inhibitor 1bnq 
Carbonic anhydrase ii inhibitor 1bnt 
Carbonic anhydrase ii inhibitor 1bnu 
Carbonic anhydrase ii inhibitor 1bnv 
Carbonic anhydrase ii inhibitor 1bnw 
Carbonic anhydrase ii inhibitor 1bv3 
Human carbonic anhydrase ii complexed with urea 1bzm 
Drug-protein interactions: structure of sulfonamide drug complexed with human carbonic anhydrase i 1ca2 
Refined structure of human carbonic anhydrase ii at 2.0 angstroms resolution 1ca3 
Unexpected ph-dependent conformation of his-64, the proton shuttle of carbonic anhydrase ii. 1cah 
Structure of cobalt carbonic anhydrase complexed with bicarbonate 1cai 
Structural analysis of the zinc hydroxide-thr 199-glu 106 hydrogen bonding network in human carbonic anhydrase ii 1caj 
Structural analysis of the zinc hydroxide-thr 199-glu 106 hydrogen bonding network in human carbonic anhydrase ii 1cak 
Structural analysis of the zinc hydroxide-thr 199-glu 106 hydrogen bonding network in human carbonic anhydrase ii 1cal 
Structural analysis of the zinc hydroxide-thr 199-glu 106 hydrogen bonding network in human carbonic anhydrase ii 1cam 
Structural analysis of the zinc hydroxide-thr 199-glu 106 hydrogen bonding network in human carbonic anhydrase ii 1can 
Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulphide and nitrate anions 1cao 
Crystallographic studies of the binding of protonated and unprotonated inhibitors to carbonic anhydrase using hydrogen sulphide and nitrate anions 1cay 
Wild-type and e106q mutant carbonic anhydrase complexed with acetate 1caz 
Wild-type and e106q mutant carbonic anhydrase complexed with acetate 1ccs 
Structure-assisted redesign of a protein-zinc binding site with femtomolar affinity 1cct 
Structure-assisted redesign of a protein-zinc binding site with femtomolar affinity 1ccu 
Structure-assisted redesign of a protein-zinc binding site with femtomolar affinity 1cil 
The positions of his-64 and a bound water in human carbonic anhydrase ii upon binding three structurally related inhibitors 1cim 
The positions of his-64 and a bound water in human carbonic anhydrase ii upon binding three structurally related inhibitors 1cin 
The positions of his-64 and a bound water in human carbonic anhydrase ii upon binding three structurally related inhibitors 1cnb 
Compensatory plastic effects in the redesign of protein- zinc binding sites 1cnc 
Compensatory plastic effects in the redesign of protein- zinc binding sites 1cng 
X-ray crystallographic studies of engineered hydrogen bond networks in a protein-zinc binding site 1cnh 
X-ray crystallographic studies of engineered hydrogen bond networks in a protein-zinc binding site 1cni 
X-ray crystallographic studies of engineered hydrogen bond networks in a protein-zinc binding site 1cnj 
X-ray crystallographic studies of engineered hydrogen bond networks in a protein-zinc binding site 1cnk 
X-ray crystallographic studies of engineered hydrogen bond networks in a protein-zinc binding site 1cnw 
Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase ii influence binding constants 1cnx 
Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase ii influence binding constants 1cny 
Secondary interactions significantly removed from the sulfonamide binding pocket of carbonic anhydrase ii influence binding constants 1cra 
The complex between human carbonic anhydrase ii and the aromatic inhibitor 1,2,4-triazole 1crm 
Structure and function of carbonic anhydrases 1cva 
Structural and functional importance of a conserved hydrogen bond network in human carbonic anhydrase ii 1cvb 
Structural and functional importance of a conserved hydrogen bond network in human carbonic anhydrase ii 1cvc 
Redesigning the zinc binding site of human carbonic anhydrase ii: structure of a his2asp-zn2+ metal coordination polyhedron 1cvd 
Structural consequences of redesigning a protein-zinc binding site 1cve 
Structural consequences of redesigning a protein-zinc binding site 1cvf 
Structural consequences of redesigning a protein-zinc binding site 1cvh 
Structural consequences of redesigning a protein-zinc binding site 1czm 
Drug-protein interactions: structure of sulfonamide drug complexed with human carbonic anhydrase i 1dca 
Structure of an engineered metal binding site in human carbonic anhydrase ii reveals the architecture of a regulatory cysteine switch 1dcb 
Structure of an engineered metal binding site in human carbonic anhydrase ii reveals the architecture of a regulatory cysteine switch 1dmx 
Murine mitochondrial carbonic anyhdrase v at 2.45 angstroms resolution 1dmy 
Complex between murine mitochondrial carbonic anyhdrase v and the transition state analogue acetazolamide 1eou 
Crystal structure of human carbonic anhydrase ii complexed with an anticonvulsant sugar sulfamate 1f2w 
The mechanism of cyanamide hydration catalyzed by carbonic anhydrase ii revealed by cryogenic x-ray diffraction 1flj 
Crystal structure of s-glutathiolated carbonic anhydrase iii 1fql 
X-ray crystal structure of zinc-bound f95m/w97v carbonic anhydrase (caii) variant 1fqm 
X-ray crystal structure of zinc-bound f93i/f95m/w97v carbonic anhydrase (caii) variant 1fqn 
X-ray crystal structure of metal-free f93i/f95m/w97v carbonic anhydrase (caii) variant 1fqr 
X-ray crystal structure of cobalt-bound f93i/f95m/w97v carbonic anhydrase (caii) variant 1fr4 
X-ray crystal structure of copper-bound f93i/f95m/w97v carbonic anhydrase (caii) variant 1fr7 
X-ray crystal structure of zinc-bound f93s/f95l/w97m carbonic anhydrase (caii) variant 1fsn 
X-ray crystal structure of metal-free f93s/f95l/w97m carbonic anhydrase (caii) variant 1fsq 
X-ray crystal structure of cobalt-bound f93s/f95l/w97m carbonic anhydrase (caii) variant 1fsr 
X-ray crystal structure of copper-bound f93s/f95l/w97m carbonic anhydrase (caii) variant 1g0e 
Site-specific mutant (his64 replaced with ala) of human carbonic anhydrase ii complexed with 4-methylimidazole 1g0f 
Site-specific mutant (his64 replaced with ala) of human carbonic anhydrase ii 1g1d 
Carbonic anhydrase ii complexed with 4-(aminosulfonyl)-n- [(2-fluorophenyl)methyl]-benzamide 1g3z 
Carbonic anhydrase ii (f131v) 1g45 
Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)-n-[(2-fluorophenyl)methyl]-benzamide 1g46 
Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)-n-[(2,3-difluorophenyl)methyl]-benzamide 1g48 
Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)-n-[(2,6-difluorophenyl)methyl]-benzamide 1g4j 
Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)-n-[(2,3,4,5,6-pentafluorophenyl)methyl]- benzamide 1g4o 
Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)-n-phenylmethylbenzamide 1g52 
Carbonic anhydrase ii complexed with 4-(aminosulfonyl)-n- [(2,3-difluorophenyl)methyl]-benzamide 1g53 
Carbonic anhydrase ii complexed with 4-(aminosulfonyl)-n- [(2,6-difluorophenyl)methyl]-benzamide 1g54 
Carbonic anhydrase ii complexed with 4-(aminosulfonyl)-n- [(2,3,4,5,6-pentafluorophenyl)methyl]-benzamide 1g6v 
Complex of the camelid heavy-chain antibody fragment cab- ca05 with bovine carbonic anhydrase 1h4n 
H94n carbonic anhydrase ii complexed with tris 1h9n 
H119n carbonic anhydrase ii 1h9q 
H119q carbonic anhydrase ii 1hca 
Unexpected ph-dependent conformation of his-64, the proton shuttle of carbonic anhydrase ii. 1hcb 
Enzyme-substrate interactions: structure of human carbonic anhydrase i complexed with bicarbonate 1hea 
Carbonic anhydrase ii (carbonate dehydratase) (hca ii) (e.c.4.2.1.1) mutant with leu 198 replaced by arg (l198r) 1heb 
Structural consequences of hydrophilic amino-acid substitutions in the hydrophobic pocket of human carbonic anhydrase ii 1hec 
Structural consequences of hydrophilic amino-acid substitutions in the hydrophobic pocket of human carbonic anhydrase ii 1hed 
Structural consequences of hydrophilic amino-acid substitutions in the hydrophobic pocket of human carbonic anhydrase ii 1hug 
Differences in anionic inhibition of human carbonic anhydrase i revealed from the structures of iodide and gold cyanide inhibitor complexes 1huh 
Differences in anionic inhibition of human carbonic anhydrase i revealed from the structures of iodide and gold cyanide inhibitor complexes 1hva 
Engineering the zinc binding site of human carbonic anhydrase ii: structure of the his-94-> cys apoenzyme in a new crystalline form 1i8z 
Carbonic anhydrase ii complexed with al-6629 2h-thieno[3,2- e]-1,2-thiazine-6-sulfonamide, 2-(3-methoxyphenyl)-3-(4- morpholinyl)-, 1,1-dioxide 1i90 
Carbonic anhydrase ii complexed with al-8520 2h-thieno[3,2- e]-1,2-thiazine-6-sulfonamide, 4-amino-3,4-dihydro-2-(3- methoxypropyl)-, 1,1-dioxide, (r) 1i91 
Carbonic anhydrase ii complexed with al-6619 2h-thieno[3,2- e]-1,2-thiazine-6-sulfonamide, 2-(3-hydroxyphenyl)-3-(4- morpholinyl)-, 1,1-dioxide 1i9l 
Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)-n-[(4-fluorophenyl)methyl]-benzamide 1i9m 
Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)-n-[(2,4-difluorophenyl)methyl]-benzamide 1i9n 
Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)-n-[(2,5-difluorophenyl)methyl]-benzamide 1i9o 
Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)-n-[(2,3,4-trifluorophenyl)methyl]-benzamide 1i9p 
Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)-n-[(2,4,6-trifluorophenyl)methyl]-benzamide 1i9q 
Carbonic anhydrase ii (f131v) complexed with 4- (aminosulfonyl)-n-[(3,4,5-trifluorophenyl)methyl]-benzamide 1if4 
Carbonic anhydrase ii complexed with 4- fluorobenzenesulfonamide 1if5 
Carbonic anhydrase ii complexed with 2,6- difluorobenzenesulfonamide 1if6 
Carbonic anhydrase ii complexed with 3,5- difluorobenzenesulfonamide 1if7 
Carbonic anhydrase ii complexed with (r)-n-(3-indol-1-yl-2- methyl-propyl)-4-sulfamoyl-benzamide 1if8 
Carbonic anhydrase ii complexed with (s)-n-(3-indol-1-yl-2- methyl-propyl)-4-sulfamoyl-benzamide 1if9 
Carbonic anhydrase ii complexed with n-[2-(1h-indol-5-yl)- butyl]-4-sulfamoyl-benzamide 1j9w 
Solution structure of the cai michigan 1 variant 1jcz 
Crystal structure of the extracellular domain of human carbonic anhydrase xii 1jd0 
Crystal structure of the extracellular domain of human carbonic anhydrase xii complexed with acetazolamide 1jv0 
The crystal structure of the zinc(ii) adduct of the cai michigan 1 variant 1keq 
Crystal structure of f65a/y131c carbonic anhydrase v, covalently modified with 4-chloromethylimidazole 1kop 
Neisseria gonorrhoeae carbonic anhydrase 1koq 
Neisseria gonorrhoeae carbonic anhydrase 1kwq 
Human carbonic anhydrase ii complexed with inhibitor 2000-07 1kwr 
Human carbonic anhydrase ii complexed with inhibitor 0134-36 1lg5 
Crystal structure analysis of the hca ii mutant t199p in complex with beta-mercaptoethanol 1lg6 
Crystal structure analysis of hca ii mutant t199p in complex with thiocyanate 1lgd 
Crystal structure analysis of hca ii mutant t199p in complex with bicarbonate 1lug 
Full matrix error analysis of carbonic anhydrase 1lzv 
Site-specific mutant (tyr7 replaced with his) of human carbonic anhydrase ii 1moo 
Site specific mutant (h64a) of human carbonic anhydrase ii at high resolution 1mua 
Structure and energetics of a non-proline cis-peptidyl linkage in an engineered protein 1okl 
Carbonic anhydrase ii complex with the 1okl inhibitor 5- dimethylamino-naphthalene-1-sulfonamide 1okm 
Carbonic anhydrase ii complex with the 1okm inhibitor 4- sulfonamide-[1-(4-aminobutane)]benzamide 1okn 
Carbonic anhydrase ii complex with the 1okn inhibitor 4- sulfonamide-[1-(4-n-(5-fluorescein thiourea)butane)] 1oq5 
Carbonic anhydrase ii in complex with nanomolar inhibitor 1ray 
The structure of human carbonic anhydrase ii in complex with bromide and azide 1raz 
The structure of human carbonic anhydrase ii in complex with bromide and azide 1rj5 
Crystal structure of the extracellular domain of murine carbonic anhydrase xiv 1rj6 
Crystal structure of the extracellular domain of murine carbonic anhydrase xiv in complex with acetazolamide 1rza 
X-ray analysis of metal substituted human carbonic anhydrase ii derivatives 1rzb 
X-ray analysis of metal substituted human carbonic anhydrase ii derivatives 1rzc 
X-ray analysis of metal substituted human carbonic anhydrase ii derivatives 1rzd 
X-ray analysis of metal substituted human carbonic anhydrase ii derivatives 1rze 
X-ray analysis of metal substituted human carbonic anhydrase ii derivatives 1t9n 
Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii 1tb0 
Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii 1tbt 
Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii 1te3 
Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii 1teq 
Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii 1teu 
Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii 1tg3 
Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii 1tg9 
Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii 1th9 
Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii 1thk 
Effect of shuttle location and ph environment on h+ transfer in human carbonic anhydrase ii 1ttm 
Human carbonic anhydrase ii complexed with 667-coumate 1uga 
Human carbonic anhydrase ii[hcaii] (e.c.4.2.1.1) mutant with ala 65 replaced by phe (a65f) 1ugb 
Human carbonic anhydrase ii[hcaii] (e.c.4.2.1.1) mutant with ala 65 replaced by gly (a65g) 1ugc 
Human carbonic anhydrase ii [hcaii] (e.c.4.2.1.1) mutant with ala 65 replaced by his (a65h) 1ugd 
Human carbonic anhydrase ii[hcaii] (e.c.4.2.1.1) mutant with ala 65 replaced by ser (a65s) 1uge 
Human carbonic anhydrase ii [hcaii] (e.c.4.2.1.1) mutant with ala 65 replaced by leu (a65l) 1ugf 
Human carbonic anhydrase ii [hcaii] (e.c.4.2.1.1) mutant with ala 65 replaced by thr (a65t) 1ugg 
Human carbonic anhydrase ii[hcaii] (e.c.4.2.1.1) mutant with ala 65 replaced by ser (a65s)-orthorhombic form 1urt 
Murine carbonic anhydrase v 1v9e 
Crystal structure analysis of bovine carbonic anhydrase ii 1v9i 
Crystal structure analysis of the site specific mutant (q253c) of bovine carbonic anhydrase ii 1xeg 
Crystal structure of human carbonic anhydrase ii complexed with an acetate ion 1xev 
Crystal structure of human carbonic anhydrase ii in a new crystal form 1xpz 
Structure of human carbonic anhydrase ii with 4-[4-o- sulfamoylbenzyl)(4-cyanophenyl)amino]-4h-[1,2,4]-triazole 1xq0 
Structure of human carbonic anhydrase ii with 4-[(3-bromo-4- o-sulfamoylbenzyl)(4-cyanophenyl)amino]-4h-[1,2,4]-triazole 1y7w 
Crystal structure of a halotolerant carbonic anhydrase from dunaliella salina 1yda 
Structural basis of inhibitor affinity to variants of human carbonic anhydrase ii 1ydb 
Structural basis of inhibitor affinity to variants of human carbonic anhydrase ii 1ydc 
Structural basis of inhibitor affinity to variants of human carbonic anhydrase ii 1ydd 
Structural basis of inhibitor affinity to variants of human carbonic anhydrase ii 1yo0 
Proton transfer from his200 in human carbonic anhydrase ii 1yo1 
Proton transfer from his200 in human carbonic anhydrase ii 1yo2 
Proton transfer from his200 in human carbonic anhydrase ii 1z93 
Human carbonic anhydrase iii:structural and kinetic study of catalysis and proton transfer. 1z97 
Human carbonic anhydrase iii: structural and kinetic study of catalysis and proton transfer. 1z9y 
Carbonic anhydrase ii in complex with furosemide as sulfonamide inhibitor 1ze8 
Carbonic anhydrase ii in complex with a membrane-impermeant sulfonamide inhibitor 1zfk 
Carbonic anhydrase ii in complex with n-4-sulfonamidphenyl- n'-4-methylbenzosulfonylurease as sulfonamide inhibitor 1zfq 
Carbonic anhydrase ii in complex with ethoxzolamidphenole as sulfonamide inhibitor 1zge 
Carbonic anhydrase ii in complex with p-sulfonamido-o,o'- dichloroaniline as sulfonamide inhibitor 1zgf 
Carbonic anhydrase ii in complex with trichloromethiazide as sulfonamide inhibitor 1zh9 
Carbonic anhydrase ii in complex with n-4-methyl-1- piperazinyl-n'-(p-sulfonamide)phenylthiourea as sulfonamide inhibitor 1znc 
Human carbonic anhydrase iv 1zsa 
Carbonic anhydrase ii mutant e117q, apo form 1zsb 
Carbonic anhydrase ii mutant e117q, transition state analogue acetazolamide 1zsc 
Carbonic anhydrase ii mutant e117q, holo form 2abe 
Carbonic anhydrase activators: x-ray crystal structure of the adduct of human isozyme ii with l-histidine as a platform for the design of stronger activators 2aw1 
Carbonic anhydrase inhibitors: valdecoxib binds to a different active site region of the human isoform ii as compared to the structurally related cyclooxygenase ii "selective" inhibitor celecoxib 2ax2 
Production and x-ray crystallographic analysis of fully deuterated human carbonic anhydrase ii 2ca2 
Crystallographic studies of inhibitor binding sites in human carbonic anhydrase ii. a pentacoordinated binding of the scn-ion to the zinc at high p*h 2cab 
Structure, refinement and function of carbonic anhydrase isozymes. refinement of human carbonic anhydrase i 2cba 
Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes 2cbb 
Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes 2cbc 
Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes 2cbd 
Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes 2cbe 
Structure of native and apo carbonic anhydrase ii and some of its anion-ligand complexes 2eu2 
Human carbonic anhydrase ii in complex with novel inhibitors 2eu3 
Human carbonic anhydrase ii in complex with novel inhibitors 2ez7 
Carbonic anhydrase activators. activation of isozymes i, ii, iv, va, vii and xiv with l- and d-histidine and crystallographic analysis of their adducts with isoform ii: engineering proton transfer processes within the active site of an enzyme 2f14 
Tne crystal structure of the human carbonic anhydrase ii in complex with a fluorescent inhibitor 2fmg 
Carbonic anhydrase activators. activation of isoforms i, ii, iv, va, vii and xiv with l- and d- phenylalanine and crystallographic analysis of their adducts with isozyme ii: sterospecific recognition within the active site of an enzyme and its consequences for the drug design, structure with l-phenylalanine 2fmz 
Carbonic anhydrase activators. activation of isoforms i, ii, iv, va, vii and xiv with l- and d- phenylalanine, structure with d-phenylalanine. 2fnk 
Activation of human carbonic anhydrase ii by exogenous proton donors 2fnm 
Activation of human carbonic anhdyrase ii by exogenous proton donors 2fnn 
Activation of human carbonic anhydrase ii by exogenous proton donors 2foq 
Human carbonic anhydrase ii complexed with two-prong inhibitors 2fos 
Human carbonic anhydrase ii complexed with two-prong inhibitors 2fou 
Human carbonic anhydrase ii complexed with two-prong inhibitors 2fov 
Human carbonic anhydrase ii complexed with two-prong inhibitors 2foy 
Human carbonic anhydrase i complexed with a two-prong inhibitor 2fw4 
Carbonic anhydrase activators. the first x-ray crystallographic study of an activator of isoform i, structure with l-histidine. 2gd8 
Crystal structure analysis of the human carbonic anhydrase ii in complex with a 2-substituted estradiol bis-sulfamate 2geh 
N-hydroxyurea, a versatile zinc binding function in the design of metalloenzyme inhibitors 2h15 
Carbonic anhydrase inhibitors: clashing with ala65 as a means of designing isozyme-selective inhibitors that show low affinity for the ubiquitous isozyme ii 2h4n 
H94n carbonic anhydrase ii complexed with acetazolamide 2hd6 
Crystal structure of the human carbonic anhydrase ii in complex with a hypoxia-activatable sulfonamide. 2hfw 
Structural and kinetic analysis of proton shuttle residues in the active site of human carbonic anhydrase iii 2hfx 
Structural and kinetic analysis of proton shuttle residues in the active site of human carbonic anhydrase iii 2hfy 
Structural and kinetic analysis of proton shuttle residues in the active site of human carbonic anhydrase iii 2hkk 
Carbonic anhydrase activators: solution and x-ray crystallography for the interaction of andrenaline with various carbonic anhydrase isoforms 2hl4 
Crystal structure analysis of human carbonic anhydrase ii in complex with a benzenesulfonamide derivative 2hnc 
Crystal structure of the human carbonic anhydrase ii in complex with the 5-amino-1,3,4-thiadiazole-2-sulfonamide inhibitor. 2hoc 
Crystal structure of the human carbonic anhydrase ii in complex with the 5-(4-amino-3-chloro-5- fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide inhibitor 2ili 
Refine atomic structure of human carbonic anhydrase ii 2it4 
X ray structure of the complex between carbonic anhydrase i and the phosphonate antiviral drug foscarnet 2nmx 
Structure of inhibitor binding to carbonic anhydrase i 2nn1 
Structure of inhibitor binding to carbonic anhydrase i 2nn7 
Structure of inhibitor binding to carbonic anhydrase i 2nng 
Structure of inhibitor binding to carbonic anhydrase ii 2nno 
Structure of inhibitor binding to carbonic anhydrase ii 2nns 
Structure of inhibitor binding to carbonic anhydrase ii 2nnv 
Structure of inhibitor binding to carbonic anhydrase ii 2nwo 
Structural and kinetic effect of hydrophobic mutations in the active site of human carbonic anhydrase ii 2nwp 
Structural and kinetic effects of hydrophobic mutations in the active site of human carbonic anhydrase ii 2nwy 
Structural and kinetic effects of hydrophobic mutations on the active site of human carbonic anhydrase ii 2nwz 
Structural and kinetic effects of hydrophobic mutations on the active site of human carbonic anhydrase ii 2nxr 
Structural effects of hydrophobic mutations on the active site of human carbonic anhydrase ii 2nxs 
Structural and kinetic effects of hydrophobic mutations in the active site of human carbonic anhydrase ii 2nxt 
Structural and kinetic effects of hydrophobic mutations in the active site of human carbonic anhydrase ii 2o4z 
Crystal structure of the carbonic anhydrase ii complexed with hydroxysulfamide inhibitor 2osf 
Inhibition of carbonic anhydrase ii by thioxolone: a mechanistic and structural study 2osm 
Inhibition of carbonic anhydrase ii by thioxolone: a mechanistic and structural study 2pou 
The crystal structure of the human carbonic anhydrase ii in complex with 4,5-dichloro-benzene-1,3-disulfonamide 2pov 
The crystal structure of the human carbonic anhydrase ii in complex with 4-amino-6-chloro-benzene-1,3-disulfonamide 2pow 
The crystal structure of the human carbonic anhydrase ii in complex with 4-amino-6-trifluoromethyl-benzene-1,3- disulfonamide 2q1b 
Carbonic anhydrase ii in complex with saccharin 2q1q 
Carbonic anhydrase inhibitors. interaction of the antiepileptic drug sulthiame with twelve mammalian isoforms: kinetic and x-ray crystallographic studies 2q38 
Carbonic anhydrase ii in complex with saccharin at 1.95 angstrom 2qo8 
Crystal structure of the complex of hcaii with an indane- sulfonamide inhibitor 2qoa 
Crystal structure of the complex of hcaii with an indane- sulfonamide inhibitor 2qp6 
The crystal structure of the complex of hcaii with a bioreductive antitumor derivative 2vva 
Human carbonic anhydrase in complex with co2 2vvb 
Human carbonic anhydrase ii in complex with bicarbonate 2w2j 
Crystal structure of the human carbonic anhydrase related protein viii 2weg 
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors 2weh 
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors 2wej 
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors 2weo 
Thermodynamic optimisation of carbonic anhydrase fragment inhibitors 2znc 
Murine carbonic anhydrase iv 3b4f 
Carbonic anhydrase inhibitors. interaction of 2- (hydrazinocarbonyl)-3-phenyl-1h-indole-5-sulfonamide with twelve mammalian isoforms: kinetic and x-ray crystallographic studies 3bet 
Crystal structure of the human carbonic anhydrase ii in complex with stx 641 at 1.85 angstroms resolution 3bl0 
Carbonic anhydrase inhibitors. interaction of 2-n,n- dimethylamino-1,3,4-thiadiazole-5-methanesulfonamide with twelve mammalian isoforms: kinetic and x-ray crystallographic studies 3bl1 
Carbonic anhydrase inhibitors. sulfonamide diuretics revisited old leads for new applications 3c7p 
Crystal structure of human carbonic anhydrase ii in complex with stx237 3ca2 
Crystallographic studies of inhibitor binding sites in human carbonic anhydrase ii. a pentacoordinated binding of the scn-ion to the zinc at high p*h 3caj 
Crystal structure of the human carbonic anhydrase ii in complex with ethoxzolamide 3cyu 
Human carbonic anhydrase ii complexed with cryptophane biosensor and xenon 3czv 
Crystal structure of the human carbonic anhydrase xiii in complex with acetazolamide 3d0n 
Crystal structure of human carbonic anhydrase xiii 3d8w 
Use of a carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti- cancer properties 3d92 
Human carbonic anhydrase ii bound with substrate carbon dioxide 3d93 
Apo human carbonic anhydrase ii bound with substrate carbon dioxide 3d9z 
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties 3da2 
X-ray structure of human carbonic anhydrase 13 in complex with inhibitor 3daz 
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties 3dbu 
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties 3dc3 
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties 3dc9 
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties 3dcc 
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties 3dcs 
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties 3dcw 
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties 3dd0 
Use of carbonic anhydrase ii, ix active-site mimic, for the purpose of screening inhibitors for possible anti-cancer properties 3dd8 
Carbonic anhydrase inhibitors. interaction of the antitumor sulfamate emd-486019 with twelve mammalian isoforms: kinetic and x-ray crystallographic studies 3dv7 
Role of hydrophilic residues in proton transfer during catalysis by human carbonic anhydrase ii (n62a) 3dvb 
X-ray crystal structure of mutant n62v human carbonic anhydrase ii 3dvc 
X-ray crystal structure of mutant n62t of human carbonic anhydrase ii 3dvd 
X-ray crystal structure of mutant n62d of human carbonic anhydrase ii 3efi 
Carbonic anhydrase activators: kinetic and x-ray crystallographic study for the interaction of d- and l- tryptophan with the mammalian isoforms i-xiv 3eft 
Crystal structure of the complex between carbonic anhydrase ii and a spin-labeled sulfonamide incorporating tempo moiety 3f4x 
Carbonic anhydrase inhibitors. comparison of chlorthalidone and indapamide x-ray crystal structures in adducts with isozyme ii: when three water molecules make the difference 3f7b 
Crystal structure of soluble domain of ca4 in complex with small molecule. 3f7u 
Crystal structure of soluble domain of ca4 in complex with small molecule. 3f8e 
Coumarins are a novel class of suicide carbonic anhydrase inhibitors 3fe4 
Crystal structure of human carbonic anhydrase vi 3ffp 
X ray structure of the complex between carbonic anhydrase ii and lc inhibitors 3gz0 
Apo-human carbonic anhydrase ii revisited: implications of the loss of a metal in protein structure, stability and solvent network 3hkn 
Human carbonic anhydrase ii in complex with (2,3,4,6-tetra- o-acetyl-beta-d-galactopyranosyl) -(1-4)-1,2,3,6-tetra-o- acetyl-1-thio-beta-d-glucopyranosylsulfonamide 3hkq 
Human carbonic anhydrase ii in complex with 1-s-d- galactopyranosylsulfonamide 3hkt 
Human carbonic anhydrase ii in complex with alpha-d- glucopyranosyl-(1->4)-1-thio-beta-d- glucopyranosylsulfonamide 3hku 
Human carbonic anhydrase ii in complex with topiramate 3iai 
Crystal structure of the catalytic domain of the tumor- associated human carbonic anhydrase ix 3ibi 
The crystal structure of the human carbonic anhydrase ii in complex with an aliphatic sulfamate inhibitor 3ibl 
The crystal structure of the human carbonic anhydrase ii in complex with an aliphatic bis-sulfamate inhibitor 3ibn 
The crystal structure of the human carbonic anhydrase ii in complex with an aliphatic bis-sulfamate inhibitor 3ibu 
The crystal structure of the human carbonic anhydrase ii in complex with an aliphatic sulfamate inhibitor 3k2f 
Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma 3znc 
Murine carbonic anhydrase iv complexed with brinzolamide 4ca2 
Engineering the hydrophobic pocket of carbonic anhydrase ii 4cac 
Refined structure of human carbonic anhydrase ii at 2.0 angstroms resolution 5ca2 
Conformational mobility of his-64 in the thr-200 (right arrow) ser mutant of human carbonic anhydrase ii 5cac 
Refined structure of human carbonic anhydrase ii at 2.0 angstroms resolution 6ca2 
Engineering the hydrophobic pocket of carbonic anhydrase ii 7ca2 
Engineering the hydrophobic pocket of carbonic anhydrase ii 8ca2 
Engineering the hydrophobic pocket of carbonic anhydrase ii 9ca2 
Engineering the hydrophobic pocket of carbonic anhydrase ii - Links (links to other resources describing this domain)
-
PFAM Carb_anhydrase INTERPRO IPR001148
